Key Elements of Microfluidics Cartridge Design for Diagnostics and Life Science Tools

Explore the essential elements of microfluidics cartridge design, from surface interactions to DfM/DfA. Learn how Wainamics streamlines cartridge development.

Developing fluidic consumable cartridges for in-vitro diagnostics (IVD) or life science research tools involves navigating a wide range of technical and usability requirements. Many of these challenges are not immediately apparent when moving from a bench-top assay to a microfluidics cartridge product.

Successful fluidic cartridge design requires a multidisciplinary approach that integrates material selection, surface chemistry, microfluidic engineering, scalable manufacturing processes, and instrument interfaces. Every element—from channel dimensions, spacing, and sensor integration to bubble traps and waste chamber design—must be carefully evaluated.

Below are three key considerations for successful microfluidics cartridge development.

1. Surface Interactions and Assay Compatibility

Bench-top assays are typically performed in tubes with low surface-to-volume ratios. In contrast, fluids in microfluidic cartridges are exposed to much higher surface areas, increasing interactions between reagents and cartridge surfaces. These effects can negatively impact assay performance by causing:

• Non-specific adsorption of biomarkers or enzymes, reducing assay sensitivity
• Shear forces within microchannels, affecting cell viability and vitality
• Laminar flow dominance, which minimizes solution homogeneity and can reduce binding efficiency

Surface modification techniques—such as dip or spray coatings, chemical vapor deposition, or hydrogel coatings—can improve compatibility. However, these treatments may complicate microfluidics manufacturing, increase cost-of-goods (COGs), and impose constraints on storage and shelf life.

To mitigate risks, early assay verification on cartridges is essential. Sub-component testing during the prototyping microfluidics stage, combined with material screening, helps ensure compatibility. At Wainamics, our in-house library of pre-screened materials and surface coatings for immunoassays, molecular amplification, and cell-based assays accelerates cartridge prototyping and material selection.

2. Design for Manufacturing and Assembly (DfM/DfA)

Microfluidics manufacturing extends far beyond injection molding of plastic parts. Many consumable cartridges integrate:

• Multiple materials such as membranes, glass microarrays, or semiconductor chips
• On-cartridge fluidic valves and precision microfeatures
• Lyophilized reagent pellets, magnetic beads, or reagent blisters

Cartridges also require sealing of fluidic channels, using methods such as lamination, ultrasonic welding, laser welding, or thermal/solvent bonding. Each approach influences bonding strength, fluid dynamics, throughput, and cost.

Successful fluidic cartridge product development requires understanding manufacturing workflows and costs early in the process. At Wainamics, we integrate DfM/DfA principles from the start and collaborate with high-volume manufacturers worldwide to deliver robust, scalable cartridge solutions.

3. Leveraging Microfluidic Phenomena Strategically

Not every feature in a fluidic cartridge needs to operate at the micro-scale. Many workflows handle both microliter and milliliter volumes. At Wainamics, our design philosophy is to apply microfluidic effects only where they provide measurable benefits, including:

• Droplet size control in microdroplet workflows
• Flow resistance tuning for uniform split distribution
• Laminar flow for controlled reactions
• Capillary-driven flow for pumpless, passive transport
• Integrated fluidic control features, including passive valving via surface-tension stops and bubble management through engineered traps

By combining micro-scale precision with larger, more robust structures, Wainamics designs sample-to-answer consumable cartridges capable of executing complex automated workflows—ranging from DNA capture and amplification to cell capture, transfection, and growth—while minimizing unnecessary complexity.

PDMS to Plastic Cartridge Transfer Considerations

In academic research, polydimethylsiloxane (PDMS) is widely used for rapid prototyping due to its ease of fabrication and bonding flexibility. However, transitioning from PDMS to manufacturing-ready plastic cartridges requires careful attention to several key elements:

• Material compatibility testing to ensure assay properties—such as cell viability and sensitivity—are preserved in plastics
• Cartridge redesign to integrate reservoirs that were previously supplied via tubing interfaces, which can significantly reduce cost of goods (COGs)
• Injection molding adaptation, since features made by soft lithography may not translate to scalable plastic manufacturing

Because of these complexities, it is best to begin microfluidics cartridge development with plastic manufacturability in mind. Launching first in PDMS and planning to transition later often results in significant additional cost and delays.

For an example, see our Organ-on-a-Chip cartridge case study

At Wainamics, we help clients manage this transition by validating material compatibility early, redesigning for injection molding, and de-risking the move from PDMS prototypes to scalable plastic cartridges.

Wainamics Expertise in Microfluidics Cartridge Development

With over a decade of experience, Wainamics provides end-to-end expertise in:

• Fluidic cartridge design and prototyping
• System architecture and bioassay integration
• DfM/DfA and scalable microfluidics manufacturing
• Consumable cartridge development for IVD and life sciences

Our proven approach helps clients avoid downstream delays, reduce manufacturing risks, and accelerate time-to-market.

Looking to streamline your Microfluidics Cartridge Development? Contact Wainamics at https://wainamics.com/#wainmamics-contact.